BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND FLT4, FLT41, 2324, ENSG00000037280, P35916, VEGFR3, PCL AND Clinical Outcome
6 results:

  • 1. Early relapse after complete remission of primary plasma cell leukaemia manifesting clonal evolution: A case report.
    Nyunt WWT; Abdul Jalil D; Zakariah NA; Abdul Karim N; Mohd Idris MR; Nasuruddin DN; Salwati SHUIB; Alauddin H; Tumian NR; Leong CF; Abdul Wahid SFS
    Malays J Pathol; 2020 Apr; 42(1):143-150. PubMed ID: 32342945
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Molecular Classification and Pharmacogenetics of Primary Plasma Cell leukemia: An Initial Approach toward Precision Medicine.
    Simeon V; Todoerti K; La Rocca F; Caivano A; Trino S; Lionetti M; Agnelli L; De Luca L; Laurenzana I; Neri A; Musto P
    Int J Mol Sci; 2015 Jul; 16(8):17514-34. PubMed ID: 26263974
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Transcriptional characterization of a prospective series of primary plasma cell leukemia revealed signatures associated with tumor progression and poorer outcome.
    Todoerti K; Agnelli L; Fabris S; Lionetti M; Tuana G; Mosca L; Lombardi L; Grieco V; Bianchino G; D'Auria F; Statuto T; Mazzoccoli C; De Luca L; Petrucci MT; Morabito F; Offidani M; Di Raimondo F; Falcone A; Omede' P; Tassone P; Boccadoro M; Palumbo A; Neri A; Musto P
    Clin Cancer Res; 2013 Jun; 19(12):3247-58. PubMed ID: 23599371
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Genetic aberrations including chromosome 1 abnormalities and clinical features of plasma cell leukemia.
    Chang H; Qi X; Yeung J; Reece D; Xu W; Patterson B
    Leuk Res; 2009 Feb; 33(2):259-62. PubMed ID: 18676019
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Expression of VEGF-C and its receptor VEGFR-3 in the bone marrow of patients with acute myeloid leukaemia.
    Liersch R; Schliemann C; Bieker R; Hintelmann H; Buechner T; Berdel WE; Mesters RM
    Leuk Res; 2008 Jun; 32(6):954-61. PubMed ID: 18006056
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Efficacy and safety of bortezomib in patients with plasma cell leukemia.
    Musto P; Rossini F; Gay F; Pitini V; Guglielmelli T; D'Arena G; Ferrara F; Filardi N; Guariglia R; Palumbo A; ; ;
    Cancer; 2007 Jun; 109(11):2285-90. PubMed ID: 17469169
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.